Fresenius Acquires Hema Metrics Business

Fresenius Medical Care AG & Co. KGaA has acquired all assets of Hema Metrics LLC related to its Crit-Line system. Financial terms of the deal were not disclosed.

Fresenius executives said the company intends to establish this technology as the standard of care for fluid and anemia management in the North American market. “The Crit-Line system is an excellent fit with Fresenius Medical Care North America’s 2008K, 2008K2, and 2008T hemodialysis machines,” Fresenius said in a news release.

The Crit-Line system enables noninvasive optical measurement of absolute blood parameters such as percent blood volume change, absolute hematocrit level and continuous oxygen saturation.

Improved fluid management may lead to fewer hospitalizations for renal patients, according to Fresenius. Accurate hematocrit measurement, real time, provides the clinician immediate feedback, supporting anemia management.

The Crit-Line system and its associated products have been cleared with the U.S. Food and Drug Administration and also carry the CE mark.